Market Tracker

12/02 5:16pm ET

TG Therapeutics Inc (NASDAQ:TGTX)

5.50
Delayed Data
As of Dec 02
 +0.05 / +0.92%
Today’s Change
4.90
Today|||52-Week Range
14.87
-53.90%
Year-to-Date
No recent news for TG Therapeutics Inc.

Today’s Trading

Previous close5.45
Today’s open5.40
Day’s range5.30 - 5.80
Volume339,282
Average volume (3 months)450,745
Market cap$298.3M
Dividend yield--
Data as of 3:59pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+15.85%
Earnings growth (this year)-1.81%
Earnings growth (next 5 years)--
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales3,573.69
Price/Book2.90

Competitors

 Today’s
change
Today’s
% change
PRTKParatek Pharmaceutic...+0.15+1.13%
SRNESorrento Therapeutic...-0.10-1.90%
OMEDOncoMed Pharmaceutic...+0.26+3.16%
RARXRa Pharmaceuticals I...+0.04+0.31%
Data as of 3:59pm ET, 12/02/2016

Financials

Next reporting dateMarch 14, 2017
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$152.4K
Annual profit (last year)-$62.9M
Net profit margin-41,310.04%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman, President &
CEO
Michael Sean Weiss
CFO, Secretary, Treasurer &
CAO
Sean A. Power
Corporate headquarters
New York, New York

Forecasts